CEO Brynjelsen Off‑loads 120,000 Shares in Tactical Liquidity Move at Eton Pharmaceuticals
Explore Eton Pharma’s insider sales: CEO Sean Brynjelsen’s tactical off‑load and its impact on the stock’s growth outlook and investor strategy.
3 minutes to read

